Lunai Bioworks Inc.(LNAI)Earnings, Financials & Key RatiosLunai Bioworks Inc. (LNAI) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2025Q3
which provides insufficient runway for sustained development.
Lunai Bioworks Inc. (LNAI) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Lunai Bioworks Inc. (LNAI) EPS & revenue vs analyst estimates — last 3 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.10 | $20,942 |
| Q1 2026 | Feb 17, 2026 | $0.08 | — |
| Q4 2025 | Nov 14, 2025 | $0.13 | — |
Recent stock market news and headlines for Lunai Bioworks Inc. (LNAI)
SACRAMENTO, Calif., June 17, 2026 /PRNewswire/ -- Fellow Shareholders, Over the past several months, Lunai Bioworks (NASDAQ: LNAI) has continued to execute its strategy of building a next-generation biotechnology company at the intersection of artificial intelligence, and national security and biology.
Lunai Bioworks Inc. shares soared 80.88% after-hours after regaining Nasdaq compliance with minimum bid price requirements.
Key metrics vs top competitors for Lunai Bioworks Inc. (LNAI)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $3.09 | $14.01M | -0.04 | — | — | -321.81% | — | |
| $33.48 | $3.44B | -41.33 | 120.01% | -49.17% | -5.89% | — | |
| $102.25 | $6.37B | -78.65 | 20.32% | -19.85% | -17.46% | — | |
| $29.25 | $1.51B | -73.13 | 13.79% | -1.98% | -2.61% | — | |
| $18.20 | $1.92B | -2.55 | 15.58% | 2.98% | 4.89% | — | |
| $17.24 | $1.93B | -4.52 | 16.92% | -597.04% | -57.27% | — |
Lunai Bioworks Inc. (LNAI) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when LNAI posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Lunai Bioworks Inc. (LNAI) stock FAQ — growth, dividends, profitability & financials explained
Lunai Bioworks Inc. (LNAI) reported $0.0M in revenue for fiscal year 2024.
Lunai Bioworks Inc. (LNAI) reported a net loss of $128.3M for fiscal year 2024.
Lunai Bioworks Inc. (LNAI) has a return on equity (ROE) of -321.8%. Negative ROE indicates the company is unprofitable.
Lunai Bioworks Inc. (LNAI) had negative free cash flow of $5.3M in fiscal year 2024, likely due to heavy capital investments.
